Non-CF Bronchiectasis

3

Review clinical trials related to Non-CF Bronchiectasis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Muco-Obstructive Lung Disease

In this study, xenon MRI will be used to evaluate regional functional consequences of mucus plugs in the lungs of patients with muco-obstructive pulmonary disease. Mucus plugs will be identified using CT imaging, and xenon MRI will be used to evaluate ventilation and gas exchange impairments in regions of the lungs corresponding to the airways downstream of mucus plugs.

Participants needed: 8
Trial details
Age: 18-65Biological sex: AllType: ObservationalSponsor: University of Kansas Medical CenterUpdated: Jul 1, 2026Locations: 1
Eligibility criteria

Adequate completion of informed consent process with written documentation [+3]

Respiratory tract infection within the 4 weeks prior to Visit 1 [+10]

Status: Recruiting

Regional Phenotyping of CF and Non-CF Bronchiectasis

The Investigators propose to study pediatric subjects who are diagnosed with cystic fibrosis (CF) and patients with non-CF bronchiectasis, with the goal of developing markers of CF lung disease severity, progression, and therapy response. The Investigator's central hypothesis is that image-based markers can forecast pathophysiology prior to spirometric changes.

Participants needed: 100
Trial details
Age: 5-100Biological sex: AllType: ObservationalSponsor: Children's Hospital Medical Center, CincinnatiUpdated: Feb 20, 2025Locations: 1
Eligibility criteria

CF Patients: Diagnosis of CF based on sweat chloride >60 mMol/l [+3]

Patients meeting standard MRI exclusions criteria (non-MRI-compatible metal impl... [+4]

Status: Recruiting

Bronchiectasis and NTM Research Registry

The Bronchiectasis Research Registry is a consolidated database of non-cystic fibrosis (non-CF) Bronchiectasis and Nontuberculosis Mycobacteria (NTM) patients from multiple clinical institutions.

Participants needed: 5,000
Trial details
Age: 18-120Biological sex: AllType: ObservationalSponsor: COPD FoundationUpdated: Mar 22, 2022Locations: 1Duration: 20 Years
Eligibility criteria

Over the age of 18 [+2]

Under the age of 18 [+1]